Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PK Interaction of Tadalafil and Tamsulosin in Healthy Volunteers
NCT02247505Phase 1Completed
- Sponsor
- Chong Kun Dang Holdings
- Start
- Sep 2014
- Primary completion
- Oct 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of tamsulosin and tadalafil in benign prostatic hyperplasia (BPH) (2 arms), sponsored by Chong Kun Dang Holdings. Primary endpoints: Tamsulosin Area Under the Curve to the last measurable concentration and Tamsulosin Maximum Plasma Concentration. Started Sep 2014; status: completed.
02
Drugs
tamsulosintadalafil
03
Conditions
benign prostatic hyperplasia (BPH)
Beyond the preview
Go deeper on NCT02247505.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02247505.